Key facts
- This page summarizes Lawrence M. Sands's Form 4 filing for VSEE HEALTH, INC. (VSEE).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Jun 2024, 19:27.
Lawrence M. Sands - 24 Jun 2024 Form 4 Insider Report for VSEE HEALTH, INC. (VSEE)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VSEE
- Reported as of
- 24 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 Jun 2024, 19:27:50 UTC
- Next SEC filing
- 26 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lawrence Sands
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lawrence M. Sands filed Form 4 for VSEE HEALTH, INC. (VSEE) on 26 Jun 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VSEE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500,000
- Date
- 24 Jun 2024
- Ownership
- See footnote 1.
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VSEE
transaction
Derivative
Series A Preferred Stock
Other
- Transaction value
- $0
- Shares
- +765
- Change %
- Price
- $0.000000
- Shares after
- 765
- Date
- 24 Jun 2024
- Ownership
- See footnote 1.
- Underlying class
- Common Stock
- Underlying amount
- 382,500
- Exercise price
- $10.00
- Footnotes
- F1, F2, F3, F4, F5
VSEE
transaction
Derivative
Series A Preferred Stock
Other
- Transaction value
- $0
- Shares
- +153
- Change %
- Price
- $0.000000
- Shares after
- 153
- Date
- 24 Jun 2024
- Ownership
- See footnote 6.
- Underlying class
- Common Stock
- Underlying amount
- 76,500
- Exercise price
- $10.00
- Footnotes
- F2, F3, F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Shares held by SCS Capital Partners, LLC ("SCS Capital") of which Reporting Person is the sole manager and sole member. As such, he has sole voting and investment power with respect to Issuer's securities held by SCS Capital. Mr. Sands disclaims beneficial ownership of such securities other than to the extent of his pecuniary interest, if any, therein, directly or indirectly.
Footnote F2
Shares of Series A preferred stock ("Series A Stock") acquired in connection with closing of the Business Combination pursuant to the terms of the Business Combination Agreement by and among Digital Health Acquisition Corp. ("DHAC"), Digital Health Merger Sub I, Inc., Digital Health Merger Sub II, Inc., VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc. (iDoc") (the "Business Combination"). In the Business Combination certain indebtedness owed by DHAC to affiliates of DHAC, among others, was converted to Series A Stock.
Footnote F3
The Series A Stock is convertible into Issuer's common stock at any time following the earlier of 12 months after the initial issuance of Series A Stock or the date on which no shares of Series A Stock remain outstanding.
Footnote F4
Not applicable.
Footnote F5
Maximum number of shares issuable.
Footnote F6
Shares held by SCS, LLC of which Reporting Person is the sole manager and sole member. As such, he has sole voting and investment power with respect to Issuer's securities held by SCS, LLC. Mr. Sands disclaims beneficial ownership of such securities other than to the extent of his pecuniary interest, if any, therein, directly or indirectly.